Milena Carla Espósito
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Milena Carla Espósito has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Danielle Aparecida Ferreira de Oliveira Marrafon
Faculty of Pharmaceutical Sciences, Federal University of Alfenas, Alfenas, Brazil
2 shared publications - Tiago Marques dos Reis
Universidade Federal de Alfenas
2 shared publications Breno Fialho Vitarelli de Carvalho
Department of Anesthesiology, pain and palliative care Santa Casa of Alfenas Alfenas Brazil
1 shared publication- Carla Speroni Ceron
Department of Biological Sciences, Institute of Exact and Biological Sciences, Federal University of Ouro Preto, Ouro Preto, Brazil
1 shared publication - Carlos Marcelo de Barros
Department of Medicine, Federal University of Alfenas (UNIFAL-MG), Rua Gabriel Monteiro da Silva, 700, Centro, Alfenas 37133-840, Minas Gerais, Brazil
1 shared publication - Denismar Alves Nogueira
Federal University of Alfenas
1 shared publication
Latest Publications
- 13 December 2022
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 50 (3) , 256-263
Oral pregabalin is effective as preemptive analgesia in abdominal hysterectomy—A randomized controlled trial
Postoperative pain is one of the main negative symptoms resulting from surgery and the use of new methods to control this symptom is of ever‐increasing relevance. Opioid‐sparing strategies, such as multimodal analgesia, are trends in this scenario. Pregabalin is a well‐established treatment for neuropathic pain; however, it is still controversial in the surgical context for postoperative analgesia. This study investigated the effect of pregabalin on postoperative analgesia in patients undergoing abdominal hysterectomy. It is a prospective, randomised, double‐blind, placebo‐controlled clinical trial. Female patients undergoing abdominal hysterectomy were randomised to use pregabalin (group P1), 300 mg orally 2 h before surgery, or identical placebo pills (group P0). The main outcome includes the postoperative pain index by visual analogue scale (VAS) and McGill's pain questionnaire. Secondary outcomes include opioid consumption and the presence of adverse effects. A value of p < 0.05 was used to reject type I error. Fifty‐five patients were randomised amongst the groups. Patients in group P1 had lower pain rates by VAS scale, both at rest and in active motion, than group P0. In McGill's questionnaire, patients from group P1 also had lower pain rates (12 × 28.5). There was approximately twice as much opioid consumption amongst patients in group P0. Regarding side effects, there was a difference between the two groups only for dizziness, being more incident in group P1. This study suggests that pregabalin is an important adjuvant drug in treating postoperative pain in patients with abdominal hysterectomy.
- 13 December 2022
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 50 (3) , 256-263
Oral pregabalin is effective as preemptive analgesia in abdominal hysterectomy—A randomized controlled trial
Postoperative pain is one of the main negative symptoms resulting from surgery and the use of new methods to control this symptom is of ever‐increasing relevance. Opioid‐sparing strategies, such as multimodal analgesia, are trends in this scenario. Pregabalin is a well‐established treatment for neuropathic pain; however, it is still controversial in the surgical context for postoperative analgesia. This study investigated the effect of pregabalin on postoperative analgesia in patients undergoing abdominal hysterectomy. It is a prospective, randomised, double‐blind, placebo‐controlled clinical trial. Female patients undergoing abdominal hysterectomy were randomised to use pregabalin (group P1), 300 mg orally 2 h before surgery, or identical placebo pills (group P0). The main outcome includes the postoperative pain index by visual analogue scale (VAS) and McGill's pain questionnaire. Secondary outcomes include opioid consumption and the presence of adverse effects. A value of p < 0.05 was used to reject type I error. Fifty‐five patients were randomised amongst the groups. Patients in group P1 had lower pain rates by VAS scale, both at rest and in active motion, than group P0. In McGill's questionnaire, patients from group P1 also had lower pain rates (12 × 28.5). There was approximately twice as much opioid consumption amongst patients in group P0. Regarding side effects, there was a difference between the two groups only for dizziness, being more incident in group P1. This study suggests that pregabalin is an important adjuvant drug in treating postoperative pain in patients with abdominal hysterectomy.
- 1 October 2021
- Published by Edra SpA in Clinical Trials in Dentistry
- Vol. 03 (03) , 03
THE FUTURE ROLE OF THE INDUSTRY IN THE DENTAL RESEARCH
- 1 October 2021
- Published by Edra SpA in Clinical Trials in Dentistry
- Vol. 03 (03) , 03
THE FUTURE ROLE OF THE INDUSTRY IN THE DENTAL RESEARCH
- Open Access
- 31 December 2020
- Published by Universidade Federal de Goias in Revista UFG
- Vol. 20
Enfrentamento à Covid-19: união de esforços para combater a disseminação do vírus
A pandemia do novo coronavírus surpreendeu todo mundo com seu início abrupto e capacidade de disseminação entre as pessoas. A lavagem das mãos é uma das medidas mais eficazes para prevenir o contágio pelo SARS-CoV-2, mas nem sempre é possível em função de demandar o uso de agua e sabão. Nesse contexto, uso do álcool etílico emerge como estratégia alternativa à higienização com água e sabão pela praticidade do uso e efetividade de ação contra o vírus. Considerando o importante papel das universidades na formação de novos profissionais, engajados com melhoria das condições sociais, e seu compromisso com a comunidade em situações de vulnerabilidade, este estudo tem por objetivo relatar a experiência da Farmácia Universitária da Universidade Federal de Alfenas no desenvolvimento de uma ação de Extensão para produção, fracionamento, envase e rotulagem de álcool etílico com fins de emprego nos serviços do Sistema Único de Saúde e demais órgãos públicos destinados ao atendimento da população.
- 31 December 2020
- Published by Universidade Federal de Goias in Revista UFG
- Vol. 20
Open AccessEnfrentamento à Covid-19: união de esforços para combater a disseminação do vírus
A pandemia do novo coronavírus surpreendeu todo mundo com seu início abrupto e capacidade de disseminação entre as pessoas. A lavagem das mãos é uma das medidas mais eficazes para prevenir o contágio pelo SARS-CoV-2, mas nem sempre é possível em função de demandar o uso de agua e sabão. Nesse contexto, uso do álcool etílico emerge como estratégia alternativa à higienização com água e sabão pela praticidade do uso e efetividade de ação contra o vírus. Considerando o importante papel das universidades na formação de novos profissionais, engajados com melhoria das condições sociais, e seu compromisso com a comunidade em situações de vulnerabilidade, este estudo tem por objetivo relatar a experiência da Farmácia Universitária da Universidade Federal de Alfenas no desenvolvimento de uma ação de Extensão para produção, fracionamento, envase e rotulagem de álcool etílico com fins de emprego nos serviços do Sistema Único de Saúde e demais órgãos públicos destinados ao atendimento da população.